Regulation of prostanoid synthesis in microglial cells and effects of prostaglandin E2 on microglial functions

Biochimie

Volumn 80, Issue 11, 1998, Pages 899-904

  Levi, Giulio ^a   Minghetti, Luisa ^a   Aloisi, Francesca ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Cyclooxygenase; Cytokines; Inflammation; Microglia; Prostaglandin

Indexed keywords

CYCLIC AMP; CYCLOOXYGENASE 2; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; LIPOPOLYSACCHARIDE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN E2; PROSTANOID; THROMBOXANE B2; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL FUNCTION; DOWN REGULATION; ENZYME INDUCTION; MICROGLIA; MOUSE; NEUROPROTECTION; NONHUMAN; PHENOTYPE; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; TIME;

ANIMALIA;

EID: 0032293476     PISSN: 03009084     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-9084(00)88886-0     Document Type: Article

References (49)

1. [1] Banati R.B., Graeber M.B., Surveillance, intervention and cytotoxicity: Is there a protective role of microglia, Dev. Neurosci. 16 (1994) 114-127.
2. [2] Mallat M., Chamak B., Brain macrophages: Neurotoxic or neurotrophic effector cells, J. Leukocyte Biol. 56 (1994) 416-422.
3. [3] Perry V.H., Lawson L.J., Reid D.M., Biology of the mononuclear phagocyte system of the central nervous system and HIV infection, J. Leukocyte Biol. 56 (1994) 399-406.
4. [4] Mc Geer P.L., McGeer E.G., The inflammatory response system of brain: Implications for therapy of Alzheimer and other neurodegenerative diseases, Brain Res. Rev. 21 (1995) 195-218.
5. [5] Kreutzberg G.W., Microglia: a sensor for pathological events in the CNS, Trends Neurosci. 19 (1996) 312-318.
6. [6] Moore S., Thanos S., The concept of microglia in relation to central nervous system disease and regeneration, Prog. Neurobiol. 48 (1996) 441-460.
7. [7] Minghetti L., Levi G., Microglia as effector cells in brain damage and repair: focus on prostanoids and nitric oxide, Prog. Neurobiol. 54 (1998) 99-125.
8. [8] Smith W.L., Mamett L.J., Dewitt D.L., Prostaglandin and thromboxane biosynthesis, in: Taylor C.W. (Ed.), Intracellular Messengers, Pergamon Press, 1993, 101 p.
9. [9] Appleton I., Tomlinson A., Willoughby D.A., Induction of cyclooxygenase and nitric oxide synthase in inflammation, Adv. Pharmacol. 35 (1996) 27-78.
10. [10] Herschman H.R., Prostaglandin synthase 2, Biochim. Biophys. Acta 1299 (1996) 125-140.
11. [11] Yamagata K., Andreasson K.I., Kaufmann W.E., Barnes C.A., Worley P.F., Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids, Neuron 11 (1993) 371-386.
12. [12] Breder C.D., Dewitt D., Kraig R.P., Characterization of inducible cyclooxygenase in rat brain, J. Comp. Neurol. 355 (1995) 296-315.
13. [13] Adams J., Collaço-Moraes Y., DeBelleroche J., Cyclooxygenase-2 induction in cerebral cortex: An intracellular response to synaptic excitation, J. Neurochem. 66 (1996) 6-13.
14. [14] Marcheselli V.L., Bazan N.G., Sustained induction of prostaglandin endoperoxide synthase-2 by seizures in hippocampus, J. Biol. Chem. 271 (1996) 24794-24799.
15. [15] Minghetti L., Levi G., Induction of prostanoid biosynthesis by bacterial lipopolysaccharide and isoproterenol in rat microglial cultures, J. Neurochem. 65 (1995) 2690-2698.
16. 2a-receptors, Glia 18 (1996) 152-160.
17. [17] O'Banion M.K., Miller J.C., Chang J.W., Kaplan M.D., Coleman P.D., Interleukin-Iβ induces prostaglandin G/H synthase-2 (cyclooxygenase-2) in primary murine astrocyte cultures, J. Neurochem. 66 (1996) 2532-2540.
18. 2 production, Glia 21 (1997) 183-193.
19. [19] Bauer M.K.A., Lieb K., Schulze-Osthoff K., Berger M., Gebicke-Haerter P.J., Bauer J., Fiebich B.L., Expression and regulation of cyclooxygenase-2 in rat microglia, Eur. J. Biochem. 243 (1997) 726-731.
20. [20] Tsubokura S., Watanabe Y., Ehara H., Imamura K., Sugimoto O., Kagamiyama H., Yamamoto S., Hayaishi O., Localization of prostaglandin endoperoxide synthase in neurons and glia in monkey brain, Brain Res. 543 (1991) 15-24.
21. [21] Elmquist J.K., Breder C.D., Sherin J.E., Scammell T.E., Hickey W.F., Dewitt D., Saper C.B., Intravenous lipopolysaccharide induces cyclooxygenase 2-like immunoreactivity in rat brain perivascular microglia and meningeal macrophages, J. Comp. Neurol. 381 (1997) 119-129.
22. [22] Shimizu T., Wolfe L.S., Arachidonic acid cascade and signal transduction, J. Neurochem. 55 (1990) 1-15.
23. [23] Farooqui A.A., Horrocks L.A., Excitatory amino acid receptors, neural membrane phospholipid metabolism and neurological disorders, Brain Res. Rev. 16 (1991) 171-191.
24. [24] Fretland D.J., Potential role of prostaglandins and leukotrienes in multiple sclerosis and experimental allergic encephalomyelitis, Prostaglandins Leuk. Essential Fatty Acids 45 (1992) 249-257.
25. [25] Griffin D.E., Wesselingh S.L., McArthur J.C., Elevated central nervous system prostaglandins in human immunodeficiency virus-associated dementia, Ann. Neurol. 35 (1994) 592-597.
26. [26] Chen J., Marsh T., Zhang J.S., Graham S.H., Expression of cyclo-oxygenase 2 in rat brain following kainate treatment, Neuroreport 6 (1995) 245-248.
27. [27] Phipps R.P., Stein S.H., Roper R.L., A new view of prostaglandin E regulation of the immune response, Immunol. Today 12 (1991) 349-352.
28. [28] Cazevieille C., Muller A., Meynier F., Dutrait N., Bonne C., Protection by prostaglandins from glutamate toxicity in cortical neurons, Neurochem. Int. 24 (1994) 395-398.
29. 2 protects cultured cortical neurons against N-methyl-D-aspartate receptor-mediated glutamate cytotoxicity, Brain Res. 663 (1994) 237-243.
30. 2 and a β-adrenergic agonist, Glia 11 (1994) 383-386.
31. [31] Reder A.T., Thapar M., Sapugay A.M., Jensen N.I.A., Prostaglandins and inhibitors of arachidonate metabolism suppress experimental allergic encephalomyelitis, J. Neuroimmunol. 54 (1994) 117-127.
32. [32] Slepko N., Levi G., Progressive activation of adult microglial cells in vitro, Glia 16 (1996) 241-246.
33. [33] Slepko N., Minghetti L., Polazzi E., Nicolini A., Levi G., Reorientation of prostanoid production accompanies 'activation' of adult microglial cells in culture, J. Neurosci. Res. 49 (1997) 292-300.
34. [34] Minghetti L., Polazzi E., Nicolini A., Créminon C., Levi G., Interferon-γ and nitric oxide down-regulate lipopolysaccharide-induced prostanoid production in cultured rat microglial cells by inhibiting cyclooxygenase-2 expression, J. Neurochem. 66 (1996) 1963-1970.
35. 2, cyclic AMP and non steroidal anti-inflammatory drugs, Eur. J. Neurosci. 9 (1997) 934-940.
36. 2 synthesis by transforming growth factor-β1 and interleukin 10 in activated microglia cultures, J. Neuroimmunol. 82 (1998) 31-39.
37. 2 and by cyclooxigenase inhibitors, Glia 19 (1997) 152-160.
38. [38] Dawson V.L., Dawson T.M., Nitric oxide neurotoxicity, J. Chem. Neuroanat. 10 (1996) 179-190.
39. 2 and cyclic AMP-elevating agents, J. Neuroimmunol. 72 (1997) 83-93.
40. [40] Lenschow D.J., Walunas T.L., Bluestone J.A., CD28/B7 system of T cell costimulation, Annu. Rev. Immunol. 14 (1996) 233-258.
41. [41] Thompson C.B., Allison J.P., The emerging role of CTLA-4 as an immune attenuator, Immunity 7 (1997) 445-450.
42. [42] Khoury S.J., Akalin E., Chandraker A., Turka L.A., Linsley P.S., Sayegh M.H., Hancock W.W., CD28-B7 costimulatory blockade by CTLA4 Ig prevents actively induced experimental autoimmune encephalomyelitis and inhibits Th1 but spares Th2 cytokines in the central nervous system, J. Immunol. 155 (1995) 4521-4524.
43. [43] Erickson K.L., Howard A.D., Hubbard N.E., Induction and modulation of macrophage Ia antigen expression by platelet-activating factor, J. Leukocyte Biol. 62 (1997) 845-851.
44. [44] Moore K.W., O'Garra A., DeWaal Malefyt R., Vieira P., Mosmann T.R., Interleukin-10, Annu. Rev. Immunol. 11 (1993) 165-190.
45. [45] Rothwell N.J., Luheshi G.N., Brain TNF damage limitation or damaged reputation, Nature Med. 2 (1996) 746-747.
46. [46] Hendrzak J.A., Brunda M.J., Biology of disease: interleukin 12, Biologic activity, therapeutic utility, and role in disease, Lab. Invest. 72 (1995) 619-637.
47. [47] Aloisi F., Penna G., Cerase J., Menèndez Iglesias B., Adorini L., IL-12 production by central nervous system microglia is inhibited by astrocytes, J. Immunol. 159 (1997) 1604-1612.
48. [48] Khoury S.J., Hancock W.W., Weiner H.L., Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor interleukin 4 and prostaglandin E expression in the brain, J. Exp. Med. 176 (1992) 1355-1364.
49. [49] Mc Geer P.L., McGeer E.G., The inflammatory response system of brain: Implications for therapy of Alzheimer and other neurodegenerative diseases, Brain Res. Rev. 21 (1995) 195-221.